Skip links and keyboard navigation

Queensland Clinical Trials Coordination Unit (QCTCU)

Queensland Clinical Trials Coordination Unit (QCTCU)

The Queensland Clinical Trials Coordination Unit (QCTCU) sits within the Health Innovation, Investment and Research Office (HIIRO) in the Office of the Director-General, Queensland Health. To make Queensland the most attractive state to conduct clinical trials  QCTCU’s role is to initiate coordination of clinical trial sites and services. To facilitate approvals, QCTCU is also responsible for monitoring and streamlining research ethics and governance processes and managing intellectual property assets.


Clinical Trials Liaison Service

Our Clinical Trials Liaison Officers (CTLOs) act as a single point of contact for clinical trial sponsors who wish to conduct a clinical trial in Queensland. Contact us to use our complimentary concierge service to find a site for a clinical trial, or to locate any other clinical trial service provider.

To access current and historical Queensland Health authorised research, click here to open DORA 2.0—the database of research activity 2.0.

Queensland Clinical Trial Site Capability Portal

Research Ethics and Governance Service

Our Research Ethics and Governance team is responsible for consultation, development and review of State-wide research ethics and research governance policies.

We provide a central portal for Researchers, Human Research Ethics Committee Chairs and Members, Coordinators, Research Governance Offices/Officers and study sponsors seeking advice and direction on ethical and governance issues associated with the conduct of research in Queensland Health.

Application form and information on the process for submission for the release of confidential information for the purposes of research under Section 280 of the Public Health Act 2005 are available in this portal.

Intellectual Property and Commercialisation Service

Our Intellectual Property and Commercialisation team supports the translation of research into improved patient outcomes, new practices and commercial products. Advice can be found here.

Last updated: 8 February 2019